General Information of Drug (ID: DMCOLUP)

Drug Name
Levallorphan Drug Info
Synonyms
Levallofano; Levallorphane; Levallorphanum; Levalorfano; Naloxiphan; Levallofano [DCIT]; Levallorphan [INN:BAN]; Levallorphane [INN-French]; Levallorphanum [INN-Latin]; Levalorfano [INN-Spanish]; Lorfan (TN); Ro-1-7700; N-Allyl-3-hydroxymorphinan; L-N-Allyl-3-hydroxymorphinan; Levo-3-hydroxy-N-allyl morphinan; (-)-3-Hydroxy-N-allylmorphinan; 17-Allylmorphinan-3-ol; 17-prop-2-en-1-ylmorphinan-3-ol
Therapeutic ClassAntinarcotic Agents
Cross-matching ID
PubChem CID
5359371
ChEBI ID
CHEMBL1254682
CAS Number
CAS 152-02-3
TTD Drug ID
D04QWE

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
DNA replication 2.14 0.00e+0 34/36 (94.44%) PRIM2;POLE3;FEN1;...
Retinol metabolism 1.89 5.58e-3 41/68 (60.29%) AOX1;DHRS3;UGT2A3;...
One carbon pool by folate 1.84 1.49e-2 15/20 (75%) MTR;DHFR;AMT;...
Asthma 1.76 4.18e-2 25/31 (80.65%) CD40;HLA-DQA1;FCER1A;...
Tyrosine metabolism 1.73 4.46e-2 30/36 (83.33%) AOX1;DCT;MAOB;...
Staphylococcus aureus infection -1.76 4.51e-2 72/95 (75.79%) ITGB2;KRT10;SELPLG;...
Oxidative phosphorylation -1.87 2.25e-2 93/133 (69.92%) NDUFB8;COX11;NDUFA2;...
Complement and coagulation cascades -1.92 3.61e-2 76/85 (89.41%) C4BPB;CFI;C8B;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 1.11uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 1.11uM - 10uM 24H